Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study) (Trident)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02013674
Recruitment Status : Unknown
Verified September 2017 by Joshua M Hare, University of Miami.
Recruitment status was:  Active, not recruiting
First Posted : December 17, 2013
Last Update Posted : September 14, 2017
Sponsor:
Collaborator:
The Emmes Company, LLC
Information provided by (Responsible Party):
Joshua M Hare, University of Miami

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Unknown
Actual Primary Completion Date : March 2, 2017
Estimated Study Completion Date : June 2019
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 October 19, 2017
(Canceled - Date Unknown)
May 30, 2018
June 28, 2018